| Tag | Content |
|---|
EnhancerAtlas ID | HS105-56854 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr3:113501460-113503070 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr3:113501469-113501481 | GTTTGTTTGTTT | + | 6.32 | | HES2 | MA0616.2 | chr3:113501611-113501621 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr3:113501611-113501621 | GGCACGTGCC | - | 6.02 | | JUN | MA0488.1 | chr3:113502591-113502604 | TCAATGATGTCAT | + | 6 | | JUND(var.2) | MA0492.1 | chr3:113502590-113502605 | GTCAATGATGTCATA | + | 6.05 | | Nfe2l2 | MA0150.2 | chr3:113502431-113502446 | TGCAGAGTCATTCTG | - | 6.73 | | Nr2f6(var.2) | MA0728.1 | chr3:113501689-113501704 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09698 | chr3:113501519-113503980 | CD14 | | SE_37632 | chr3:113500931-113504026 | HSMMtube |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr3 | 113502340 | 113502710 | | chr3 | 113502348 | 113502517 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I113782 | chr3 | 113501449 | 113503926 |
|
Enhancer Sequence | GGTTTTTTTG TTTGTTTGTT TGCTTTTTGA GACAGAGTCT CACTCTGTCG CCCAGGCTGG 60
AGTGCAGTAG CATGATCTCG GCTTACTGCA ACCTCCGCCT CCCAGGTTTG AGCAATTCTC 120
TGCCTCAGCC TCCCAAGTAG CTGGGATTAC AGGCACGTGC CAGCATGCCC GGCTAATTTT 180
TTGTATTTTT AGTAGAGATG GGGTTTCACC ATCTTGGCCA GGCTGGTCTT GAACTCCTGA 240
CCTCACGATC CACCTGCCCC GGCCTCCCAA GATAGCATAT TTTAGGTACT GTTATACACC 300
TTGCTTTTTT TCACTTAAAA GTATGTGTAT TCTAGAAGAT AAATAGATAT GTGATAAATA 360
TAGTAAAATG TTAAATATAG AACCTAGCTT GTAGAGACTG GGAGTCCACT GTAAAATTCT 420
TTCAACTTTG TTGTTGTTCT GAAAATTTTC ATAATCAAAA TTGGAAATGA AAATACATAG 480
TTTAGAGAGA TTTCTAGAGG AATTCATGAT AACTCTGGTT CTTTTTTTTA CAGCCATATA 540
ACAATTCCAT CATATAAATG TACCATTATT TACTTATCAA TGTCTTAATG ATAGAAGTTT 600
TGGTTTCTAG TTTTTGGTTG TTATAAACAG TGCTACATTG TAAGTATAGT AAGAATTCAC 660
AGAAGTTGGA TTCCTAGGTC ACGACTTACC CATTTTGAAT TTTGATAAAT ATTGCTAAAT 720
TGCTCTCAGG AAAAGTTGTA CTGATTTTAC TCCTGTCAAC AAATGTGTAG AATAAAGTGG 780
ACTCATTATG CTTATTTATA TATTTTATTC TTATTTGTAT GTTTTCAAAA TAACTTTATT 840
CTTAAGATTT TAGGTTTTGT CCAAGTACTA ATACCCTTAT TAGGGGACTG ATATTCCTCA 900
GCAGCATATG TGAAGCAATG TATTAATGAG GGAGTTTTGC TTCTGTTTTT AGCCCTGTGG 960
TTCCCAAACT TTGCAGAGTC ATTCTGAGAA GCTGCAGCAA ACTCATGTGG TGCCAGGATA 1020
TTTAAAATTT TTGAGGCAAA CACAGGAATG TTAGACATAT TGTCAGACAC CACATGAACT 1080
AGTAGCTTGA GATAATAAAC AGTTTCATTA TGTTGCTGTA CTATATTTTT GTCAATGATG 1140
TCATATCTTT GCAAAGCTGA GTTTTTGGCA GTTGCTAAGC TACAAAAGCA GGTATCATGT 1200
GACAATCAAA ATGGAACAAG TTTCCAATCT GATTGCAAGA TTGGAAAATT ATATAGTTCC 1260
CCAAGGGCAT ATACATTCAT GAGAATTATG GATATTTAGG ACTGAAATTA ATATTATTTT 1320
TTCTTTCAAC TTATGCATAT ATTTTTTCAA ATTGCTACTC AGTTGTTAGG ACGTATATAC 1380
ATATTAGGTT GTTTAGACAT AACTGTTTAA TAAATGCAAG TGTTAGATAT ATCTTTTGTC 1440
CTGGGACACT GAAAGAAGTT ACTGAAAACA CTATGAATCC TGTGAACTGA GAAAGTTTGG 1500
GAACTTCCGT TTTCACTTCT TGAGTGGCAT TTCCTTGTTA AACTGTGGTA TTTCCTGTTA 1560
ATTGTGTCTT TAAACCTTCA TAGTAGGTTT TCCTTAGCTG CTGTTTTTAG 1610
|
